ES8405155A1 - Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis. - Google Patents

Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis.

Info

Publication number
ES8405155A1
ES8405155A1 ES522917A ES522917A ES8405155A1 ES 8405155 A1 ES8405155 A1 ES 8405155A1 ES 522917 A ES522917 A ES 522917A ES 522917 A ES522917 A ES 522917A ES 8405155 A1 ES8405155 A1 ES 8405155A1
Authority
ES
Spain
Prior art keywords
ethosuximide
antibodies
immunoassay method
immunogens
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522917A
Other languages
English (en)
Other versions
ES522917A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Publication of ES8405155A1 publication Critical patent/ES8405155A1/es
Publication of ES522917A0 publication Critical patent/ES522917A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/075—Benzo[b]pyran-2-ones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials

Abstract

PROCEDIMIENTO DE INMUNOANALISIS PARA DETERMINAR ETOSUXIMIDA EN UNA MUESTRA DE ANALISIS.COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE PREPARA UN ANTICUERPO CONTRA UN INMUNOGENO QUE COMPRENDE ETOSUXIMIDA COVALENTEMENTE ENLAZADA EN SU POSICION 3 A UN MATERIAL SOPORTE INMUNOGENICO; SEGUNDA, LA MUESTRA DE ANALISIS SE COMBINA CON UN ANTICUERPO DE ETOSUXIMIDA Y UNA FORMA RADIOMARCADA DE ETOSUXIMIDA; Y POR ULTIMO, LA CANTIDAD DE ETOSUXIMIDA MARCADA QUE LLEGA A LIGARSE POR EL ANTICUERPO SE DETERMINA COMO UNA FUNCION DE ETOSUXIMIDA EN DICHA MUESTRA.
ES522917A 1982-06-01 1983-06-01 Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis. Granted ES522917A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38359982A 1982-06-01 1982-06-01

Publications (2)

Publication Number Publication Date
ES8405155A1 true ES8405155A1 (es) 1984-05-16
ES522917A0 ES522917A0 (es) 1984-05-16

Family

ID=23513862

Family Applications (1)

Application Number Title Priority Date Filing Date
ES522917A Granted ES522917A0 (es) 1982-06-01 1983-06-01 Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis.

Country Status (6)

Country Link
EP (1) EP0095665B1 (es)
JP (1) JPS5916874A (es)
AU (1) AU540288B2 (es)
DE (1) DE3365111D1 (es)
ES (1) ES522917A0 (es)
IL (1) IL68364A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118899A (en) * 1986-12-22 1992-06-02 Phillips Petroleum Company Composition of matter and method of oxidative conversion of organic compounds therewith

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1511571A (en) * 1974-06-28 1978-05-24 Syva Co Lactam compounds and conjugates

Also Published As

Publication number Publication date
DE3365111D1 (en) 1986-09-11
AU1347583A (en) 1983-12-15
AU540288B2 (en) 1984-11-08
EP0095665B1 (en) 1986-08-06
EP0095665A1 (en) 1983-12-07
ES522917A0 (es) 1984-05-16
JPS5916874A (ja) 1984-01-28
IL68364A0 (en) 1983-07-31
IL68364A (en) 1986-07-31

Similar Documents

Publication Publication Date Title
JPS5530692A (en) Method of immunological measuring
ATE14630T1 (de) Creatinin-antikoerper.
PT89889A (pt) Processo para a preparacao de testes imunologicos contendo derivados de igg polimericos para a compensacao de factores perturbantes
FI903515A0 (fi) Testimenetelmä ja reagenssikitti sitä varten
DE3381781D1 (de) Hochspezifisches antiserum gegen prokollagen-peptid col 1 (typ iii) und prokollagen-peptid (typ iii), seine herstellung und verwendung.
FI90799C (fi) Immunologisia määritysmenetelmiä ja niissä käytettävä reagenssi
EP0152477A4 (en) MONOCLONAL ANTIBODIES AGAINST ONCOPROTEINS INDUCED BY POLYPEPTIDES.
FI89984C (fi) Enstegsimmuntest foer bestaemning av antigenspecifika antikroppar hoerande till immunoglobulingruppen a, m, d eller e och medel daerfoer
DE3576854D1 (de) Immunchemisches messverfahren fuer haptene und proteine.
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
EP0383313A3 (en) Reagent for immunoassay, and kit containing the same
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
NO874140D0 (no) Immunometriske bestemmelsesfremgangsmaater.
ES8503855A1 (es) Procedimiento de inmunoanalisis homogeneo para determinar un analito en una muestra de ensayo.
KR900006779A (ko) 항원에 대해 특이적인 종류의 항체 측정 방법 및 이 방법을 실행하기 위한 시약
ES8405155A1 (es) Procedimiento de inmunoanalisis para determinar etosuximida en una muestra de analisis.
ES8500455A1 (es) Procedimiento de inmunoanalisis para determinar disopiramida en medios liquidos
ES8608321A1 (es) Hibridomas productores de anticuerpos monoclonales especifi-cos para la inmunoglobulina e (ige)humana del mieloma ns